标题
Phosphodiesterase 10 inhibitors in clinical development for CNS disorders
作者
关键词
-
出版物
Expert Review of Neurotherapeutics
Volume 17, Issue 6, Pages 553-560
出版商
Informa UK Limited
发表日期
2016-12-04
DOI
10.1080/14737175.2017.1268531
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Phosphodiesterase 10A in Schizophrenia: A PET Study Using [11C]IMA107
- (2016) Tiago Reis Marques et al. AMERICAN JOURNAL OF PSYCHIATRY
- The effects of PDE10 inhibition on attentional set-shifting do not depend on the activation of dopamine D1 receptors
- (2016) Agnieszka Nikiforuk et al. BEHAVIOURAL PHARMACOLOGY
- Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy
- (2016) Yu-Wen Li et al. NEUROPHARMACOLOGY
- TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms
- (2016) Kazunori Suzuki et al. NEUROPSYCHOPHARMACOLOGY
- Differential Dopamine Regulation of Ca 2+ Signaling and Its Timing Dependence in the Nucleus Accumbens
- (2016) Immani Swapna et al. Cell Reports
- A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson’s Disease
- (2016) Patrick Roberts et al. Frontiers in Pharmacology
- Discovery of [ 11 C ] MK - 8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors
- (2015) Christopher D. Cox et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Altered PDE10A expression detectable early before symptomatic onset in Huntington’s disease
- (2015) Flavia Niccolini et al. BRAIN
- Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson’s disease
- (2015) Flavia Niccolini et al. BRAIN
- Treatment of Cognitive Impairment in Schizophrenia: Potential Value of Phosphodiesterase Inhibitors in Prefrontal Dysfunction
- (2015) Marlies Duinen et al. CURRENT PHARMACEUTICAL DESIGN
- Characterisation of Lu AF33241: A novel, brain-penetrant, dual inhibitor of phosphodiesterase (PDE) 2A and PDE10A
- (2015) John P. Redrobe et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Facilitation of Corticostriatal Transmission following Pharmacological Inhibition of Striatal Phosphodiesterase 10A: Role of Nitric Oxide-Soluble Guanylyl Cyclase-cGMP Signaling Pathways
- (2015) F. E. Padovan-Neto et al. JOURNAL OF NEUROSCIENCE
- Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [11C]MK-8193
- (2015) Eric D. Hostetler et al. MOLECULAR IMAGING AND BIOLOGY
- Molecular Imaging of PDE10A Knockout Mice with a Novel PET Radiotracer: [11C]T-773
- (2015) Miklós Tóth et al. MOLECULAR IMAGING AND BIOLOGY
- Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject
- (2015) Hui Liu et al. NEUROIMAGE
- Phosphodiesterase 10A inhibitor, MP-10 (PF-2545920), produces greater induction of c-Fos in dopamine D2 neurons than in D1 neurons in the neostriatum
- (2015) Jonathan M. Wilson et al. NEUROPHARMACOLOGY
- Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
- (2015) Richard SE Keefe et al. NEUROPSYCHOPHARMACOLOGY
- Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A
- (2015) Akina Harada et al. NUCLEAR MEDICINE AND BIOLOGY
- Pharmacological evaluation of a novel phosphodiesterase 10A inhibitor in models of antipsychotic activity and cognition
- (2015) Philip G. Jones et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Evaluation of a novel PDE10APET radioligand, [11C]T-773, in nonhuman primates: Brain and whole body PET and brain autoradiography
- (2015) Akihiro Takano et al. SYNAPSE
- Translating the MAM model of psychosis to humans
- (2015) Gemma Modinos et al. TRENDS IN NEUROSCIENCES
- L-Stepholidine rescues memory deficit and synaptic plasticity in models of Alzheimer’s disease via activating dopamine D1 receptor/PKA signaling pathway
- (2015) J-R Hao et al. Cell Death & Disease
- Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10
- (2015) Nan Li et al. Oncotarget
- The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review
- (2014) J. Peuskens et al. CNS DRUGS
- Phosphodiesterase 10 Inhibitors: New Disease Modifying Drugs for Parkinson’s Disease?
- (2014) A.M. Garcia et al. CURRENT MEDICINAL CHEMISTRY
- Emerging Biology of PDE10A
- (2014) Lindsay Wilson et al. CURRENT PHARMACEUTICAL DESIGN
- Multitarget drug discovery projects in CNS diseases: quantitative systems pharmacology as a possible path forward
- (2014) Hugo Geerts et al. Future Medicinal Chemistry
- Discovery of a Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitor for the Potential Treatment of Schizophrenia
- (2014) José Manuel Bartolomé-Nebreda et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Clinical Candidate 1-(4-(3-(4-(1H-Benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), A Potent, Selective, and Efficacious Inhibitor of Phosphodiesterase 10A (PDE10A)
- (2014) Essa Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vivo Assessment and Dosimetry of 2 Novel PDE10A PET Radiotracers in Humans: 18F-MNI-659 and 18F-MNI-654
- (2014) O. Barret et al. JOURNAL OF NUCLEAR MEDICINE
- Discovery and Development of 11C-Lu AE92686 as a Radioligand for PET Imaging of Phosphodiesterase10A in the Brain
- (2014) J. Kehler et al. JOURNAL OF NUCLEAR MEDICINE
- Dopaminergic manipulations and its effects on neurogenesis and motor function in a transgenic mouse model of Huntington's disease
- (2014) M.L. Choi et al. NEUROBIOLOGY OF DISEASE
- Neurodegenerative diseases in a dish: the promise of iPSC technology in disease modeling and therapeutic discovery
- (2014) Y. Z. Xie et al. NEUROLOGICAL SCIENCES
- Phosphodiesterase 10A Regulates Alcohol and Saccharin Self-Administration in Rats
- (2014) Marian L Logrip et al. NEUROPSYCHOPHARMACOLOGY
- Effects of the D1 Dopamine Receptor Agonist Dihydrexidine (DAR-0100A) on Working Memory in Schizotypal Personality Disorder
- (2014) Daniel R Rosell et al. NEUROPSYCHOPHARMACOLOGY
- Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates
- (2014) Dah-Ren Hwang et al. NUCLEAR MEDICINE AND BIOLOGY
- Prior Antipsychotic Drug Treatment Prevents Response to Novel Antipsychotic Agent in the Methylazoxymethanol Acetate Model of Schizophrenia
- (2014) K. M. Gill et al. SCHIZOPHRENIA BULLETIN
- Time for New Schizophrenia Rx
- (2014) S. E. Hyman SCIENCE
- Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis
- (2014) Shu-Fei Lin et al. SYNAPSE
- Inhibition of phosphodiesterase10A attenuates morphine-induced conditioned place preference
- (2014) Ying Mu et al. Molecular Brain
- Adaptive deep brain stimulation in advanced Parkinson disease
- (2013) Simon Little et al. ANNALS OF NEUROLOGY
- PDE2 and PDE10, but not PDE5, inhibition affect basic auditory information processing in rats
- (2013) O.A.H. Reneerkens et al. BEHAVIOURAL BRAIN RESEARCH
- Optogenetic insights into striatal function and behavior
- (2013) Jeffrey D. Lenz et al. BEHAVIOURAL BRAIN RESEARCH
- PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model
- (2013) Albert Giralt et al. HIPPOCAMPUS
- PET imaging shows loss of striatal PDE10A in patients with Huntington disease
- (2013) R. Ahmad et al. NEUROLOGY
- Phosphodiesterase 10A inhibitor MP-10 effects in primates: Comparison with risperidone and mechanistic implications
- (2013) Subramaniam Uthayathas et al. NEUROPHARMACOLOGY
- A Gαs DREADD Mouse for Selective Modulation of cAMP Production in Striatopallidal Neurons
- (2013) Martilias S Farrell et al. NEUROPSYCHOPHARMACOLOGY
- Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801
- (2012) Olga A.H. Reneerkens et al. BEHAVIOURAL BRAIN RESEARCH
- The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey
- (2012) Sean M. Smith et al. NEUROPHARMACOLOGY
- N-Acylhydrazones as inhibitors of PDE10A
- (2011) Jennifer L. Gage et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia
- (2011) Jan Kehler et al. CURRENT PHARMACEUTICAL DESIGN
- The internal state of medium spiny neurons varies in response to different input signals
- (2010) Zhen Qi et al. BMC Systems Biology
- Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia
- (2010) Barbara Picconi et al. BRAIN
- Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease
- (2010) Carmela Giampà et al. PLoS One
- PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system
- (2009) Lars S. Kruse et al. BRAIN RESEARCH
- Of Mice and Men
- (2009) Hugo Geerts CNS DRUGS
- Distinct Roles of PDE4 and PDE10A in the Regulation of cAMP/PKA Signaling in the Striatum
- (2008) A. Nishi et al. JOURNAL OF NEUROSCIENCE
- Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia
- (2008) C. J. Schmidt et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- l-Stepholidine reduced l-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease
- (2008) Jiao Mo et al. NEUROBIOLOGY OF AGING
- Imaging dopamine release with Positron Emission Tomography (PET) and 11C-raclopride in freely moving animals
- (2008) Vinal D. Patel et al. NEUROIMAGE
- Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine
- (2008) M. Weber et al. PSYCHOPHARMACOLOGY
- The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D1 agonist and D2 antagonist
- (2008) Sridhar Natesan et al. PSYCHOPHARMACOLOGY
- THE EFFECT OF ARIPIPRAZOLE ON PREPULSE INHIBITION OF THE STARTLE RESPONSE IN NORMAL AND HYPERDOPAMINERGIC STATES IN RATS
- (2007) SATORU NAKAI et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started